BioPartner Nordic ApS: Financial statements 2022
CVR: 38153188
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
BioPartner Nordic ApS (CVR 38153188) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -13,217 and a net result of DKK -42,541 compared with DKK -10,713 the year before. Equity in the 2022 report amounted to DKK -115,346.
- Gross Profit
- DKK -13,217
- Profit/Loss
- DKK -42,541
- Equity
- DKK -115,346
- Total Assets
- DKK 28,834
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -13K | -43K | -115K | - |
| 2021 | 121K | 23K | -11K | 5K | - |
| 2020 | 240K | 78K | 56K | -62K | - |
| 2019 | 58K | -137K | -167K | -118K | - |
| 2018 | 587K | 185K | 185K | 50K | - |
Official annual report
Keep an eye on BioPartner Nordic ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
BioPartner Nordic ApS has published its annual report for 2021. Revenue came to DKK 121,400, and the net result was DKK -10,713.
About BioPartner Nordic ApS
BioPartner Nordic ApS is a Danish company of the type Anpartsselskab based in Hedehusene, founded in 2016. The company is registered under the industry Anden teknisk rådgivning. The management consists of John Holger Schultz. The company is owned by John Holger Schultz. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -7,778 and a net result of DKK -27,378 compared with DKK -79,721 the year before. Equity in the 2025 report amounted to DKK 22,622.
